US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

NRXP NRX Pharmaceuticals Inc

3.03

-0.41 (-11.92%)

14 Jun 2024 - Cerrado

Retrasado por 15 minutos

Form 3 - Initial statement of beneficial ownership of securities

NRX Pharmaceuticals (NASDAQ:NRXP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas NRX Pharmaceuticals.

NRX Pharmaceuticals (NASDAQ:NRXP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas NRX Pharmaceuticals.

Noticias sobre NRX Pharmaceuticals Inc NRXP

NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter
Lunes 10 de Junio 2024 (6 días hace) • PR Newswire (US)

NRx Pharmaceuticals (Nasdaq:NRXP) Presents Landmark Trial of NRX-101 in Suicidal Bipolar Depression At the American Society of Clinical Psychopharmacology Annual Meeting: NRX-101 is the First Oral Antidepressant Demonstrated to Reduce Suicidality in Bipola
Martes 28 de Mayo 2024 (3 semanas hace) • PR Newswire (US)

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update
Martes 14 de Mayo 2024 (1 mes hace) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024
Miércoles 8 de Mayo 2024 (1 mes hace) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024
Martes 7 de Mayo 2024 (1 mes hace) • PR Newswire (US)

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression
Lunes 6 de Mayo 2024 (1 mes hace) • PR Newswire (US)

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression
Martes 30 de Abril 2024 (2 meses hace) • PR Newswire (US)

NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement
Jueves 18 de Abril 2024 (2 meses hace) • PR Newswire (US)

NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
Jueves 18 de Abril 2024 (2 meses hace) • PR Newswire (US)

NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
Miércoles 17 de Abril 2024 (2 meses hace) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections
Miércoles 17 de Abril 2024 (2 meses hace) • PR Newswire (US)

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
Lunes 15 de Abril 2024 (2 meses hace) • PR Newswire (US)

Más de NRX Pharmaceuticals Inc Artículos de Noticias

American Express

Deutsche Telekom (QX)

Gold vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones